Nội dung toàn văn Decision No. 2301/QD-BYT guidance pre-vaccination screening examination for children 2015
MINISTRY OF HEALTH | SOCIALIST REPUBLIC OF VIETNAM |
No.: 2301/QD-BYT | Hanoi, June 12, 2015 |
DECISION
PROMULGATING GUIDANCE FOR PRE-VACCINATION SCREENING EXAMINATION FOR CHILDREN
MINISTER OF HEALTH
Pursuant to the Government’s Decree No. 63/2012/ND-CP dated August 31, 2012 defining the functions, tasks, powers and organizational structure of Minister of Health;
At the request of the Director General of the Administration of Medical Examination & Treatment - the Ministry of Health.
DECIDES:
Article 1. To promulgate under this Decision the Guidance for pre-vaccination screening examination for children.
Article 2. This decision takes effect from the date of signing. The Decision No. 04/QD-BYT dated January 02, 2014 of the Minister of Health promulgating guidance for pre-vaccination screening examination for children shall be abrogated.
Article 3. The Chief of Ministerial Office, Director General of the Administration of Medical Examination & Treatment, Ministerial Chief Inspector, General Directors of Departments/Administrations of the Ministry of Health; Directors of medical facilities directly under the Ministry of Health; Directors of Services of Health of central-affiliated cities or provinces; Heads of medical agencies of Ministries and sectors; Heads of relevant units shall implement this Decision./.
| PP. MINISTER |
GUIDANCE
FOR PRE-VACCINATION SCREENING EXAMINATION FOR CHILDREN
(Promulgated under the Decision No. 2301/QD-BYT dated June 12, 2015)
I. Purpose of screening examination:
The purpose of screening examination is to discover any abnormal cases requiring attention to decide whether the child should be vaccinated.
II. Contraindications and suspension of vaccination
1. Contraindications:
a) Children have medical history as shock or severe reaction after the previous vaccination (of same vaccine ingredients) with the following symptoms: have a high fever of 39°C or more with recurrent convulsions or brain/meningeal signs, cyanosis and dyspnea.
b) Children have organ failure (such as respiratory failure, circulatory failure, heart failure, renal failure, liver failure, etc.)
c) Attenuated vaccine is contraindicated for children having immunodeficiency (having primary immunodeficiency, clinical stage 4 HIV-infected children or having severe symptoms of immunodeficiency).
d) BCG vaccine is not used for children of HIV-infected mothers who were not under preventive treatment and HIV can be passed from such mothers to their children.
dd) Other contraindications as instructed by manufacturer on each type of vaccine.
2. Suspension of vaccination:
a) Children have acute diseases, especially infectious diseases.
b) Children have body temperature ≥ 37.5°C or ≤ 35.5 °C (temperature at armpit).
c) Children have just used immunoglobulin for 3 months, except for cases that are using immunoglobulin for treatment of hepatitis B virus.
d) Children undergo or have just finished corticoid therapy (oral/injection) for 14 days.
dd) Children have weight of under 2000 grams.
e) Other cases of suspension of vaccination as instructed by manufacturer on each type of vaccine.
III. Organization of screening examination:
1. Personnel conducting screening examination:
- Doctors, physicians: directly take physical examination for the child and record information of that child, and directly take and record body temperature in cases of absence of nurses/midwives.
- Nurses, midwives: Record the child’s information, directly take and record body temperature of the child.
2. Facilities:
- Thermometer
- Stethoscope
- Pre-vaccination checklist for children (Annex I)
- Pre-vaccination checklist for newborn babies (Annex II)
3. Steps for pre-vaccination screening examination
Steps for conducting and filling in pre-vaccination screening checklist include:
- Ask about medical history and relevant information
- Evaluate health status at present
- Come to conclusion
4. Take notes of screening examination and keep checklist
a) Pre-vaccination screening examination conducted in hospitals:
- If the hospital uses separate medical record for newborn baby, all information of screening examination (as stated in checklist) and physician order for vaccination must be stated in medical record.
- If there is no separate medical record for newborn baby, all information of screening examination shall be recorded according to the checklist. Checklist shall be kept in medical record files.
Period for keeping shall comply with regulations on keeping medical record files.
b) Pre-vaccination screening examination conducted in other vaccination facilities (other than hospitals): all information of screening examination shall be recorded according to the checklist which is kept in vaccination facilities.
Period for keeping: 15 days.
ANNEX I
(Promulgated under the Decision No. …………./QD-BYT dated ……………….)
BV/TTYTDP/TYT/PK …………………… | SOCIALIST REPUBLIC OF VIETNAM |
PRE-VACCINATION CHECKLIST FOR CHILDREN
Full name of the child: |
| Male | □ | Female | □ | |||||
Age: | Born on: day….. | month… | year…. | |||||||
Address |
|
|
| |||||||
Full name of parent: | Tel.: |
|
| |||||||
1. Shock or severe reaction after the previous vaccination: | ||||||||||
| No | □ | Yes | □ |
| |||||
2. Have acute diseases or progressive chronic diseases: | ||||||||||
| No | □ | Yes | □ |
| |||||
3. Undergo or have just finished corticoid therapy/ gamma globulin: | ||||||||||
| No | □ | Yes | □ |
| |||||
4. Fever/hypothermia (Fever: temperature ≥ 37.5oC; Hypothermia: temperature ≤ 35.5oC) | ||||||||||
| No | □ | Yes | □ |
| |||||
5. Abnormal heart beat | ||||||||||
| No | □ | Yes | □ |
| |||||
6. Abnormal breathing rates and lung sounds | ||||||||||
| No | □ | Yes | □ |
| |||||
7. Abnormal perception (lethargy or irritability) | ||||||||||
| No | □ | Yes | □ |
| |||||
8. Other contraindications | ||||||||||
| No | □ | Yes | □ |
| |||||
|
|
|
|
|
|
|
|
|
|
|
Conclusion:
- Be qualified for vaccination (There is NO abnormality) | □ |
Vaccine of this vaccination: ........................................... |
|
- Vaccine is contraindicated for this child (If having any abnormality in items 1,8) | □ |
- Vaccination is suspended (If having any abnormality in items 2, 3, 4, 5, 6, 7) | □ |
| Made at ……hour(s)……minute(s), on day………month…..year….. |
ANNEX II
(Promulgated under the Decision No. …………./QD-BYT dated ……………….)
BV/TTYTDP/TYT/PK/NHS …………………… | SOCIALIST REPUBLIC OF VIETNAM |
PRE-VACCINATION CHECKLIST FOR NEWBORN BABIES
Full name of the newborn baby: |
| Male | □ | Female | □ |
Born at………hour(s)……..on day……month……..year………
Address
Full name of parent:
Type of vaccine to be injected in this vaccination:
1. Fever/hypothermia (Fever: temperature ≥ 37.5oC; Hypothermia: temperature ≤ 35.5oC) | |||||
| No | □ | Yes | □ |
|
2. Abnormal heart beat | |||||
| No | □ | Yes | □ |
|
3. Abnormal lung sounds | |||||
| No | □ | Yes | □ |
|
4. Abnormal perception (lethargy or irritability……poor feeding…..) | |||||
| No | □ | Yes | □ |
|
5. Weight at birth is below 2000 grams: | |||||
| No | □ | Yes | □ |
|
6. Other contraindications | |||||
| No | □ | Yes | □ |
|
Conclusion:
- Be qualified for vaccination (There is NO abnormality) | □ |
Vaccine of this vaccination: ........................................... |
|
- Vaccination is suspended (If having any abnormality) | □ |
| Made at ……hour(s)……minute(s), on day………month…..year….. |
ANNEX III
(Promulgated under the Decision No. …………./QD-BYT dated ……………….)
Normal resting respiratory rates by age
Age (years) | Breaths (minute-based respiratory rates) |
Newborn | 40 - 50 |
< 1 | 30 - 40 |
1 - 2 | 25 - 35 |
2 - 5 | 25 - 30 |
5 - 12 | 20 - 25 |
>12 | 15 - 20 |
(Medical treatment guidelines – Volume III – Paediatric emergency response)
ANNEX IV
(Promulgated under the Decision No. …………./QD-BYT dated ……………….)
Normal heart rate by age
Age (year) | Beats (heart beats/minute) |
Newborn | 140 - 160 |
< 1 | 110 - 160 |
1 - 2 | 100 - 150 |
2 - 5 | 95 - 140 |
5 - 12 | 80 - 120 |
> 12 | 60 - 100 |
(Medical treatment guidelines – Volume III – Paediatric emergency response)
------------------------------------------------------------------------------------------------------
This translation is made by LawSoft and for reference purposes only. Its copyright is owned by LawSoft and protected under Clause 2, Article 14 of the Law on Intellectual Property.Your comments are always welcomed